Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud

BACKGROUND: Ivermectin is an antiparasitic drug being investigated in clinical trials for the prevention of COVID-19. However, there are concerns about the quality of some of these trials. OBJECTIVES: To conduct a meta-analysis with randomized controlled trials of ivermectin for the prevention of CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Mirchandani, Manya, Ellis, Leah, Pilkington, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326581/
https://www.ncbi.nlm.nih.gov/pubmed/35190831
http://dx.doi.org/10.1093/jac/dkac052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326581/
https://www.ncbi.nlm.nih.gov/pubmed/35190831
http://dx.doi.org/10.1093/jac/dkac052

Ejemplares similares